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TO THE EDITOR
Epidermodysplasia verruciformis (EV),
an infrequently reported lifelong
clinical entity, is characterized by ab-
normal susceptibility to human papillo-
maviruses (HPVs). The natural course of
the disease may at times be punctuated
by the transformation of EV into squa-
mous cell carcinoma; the lesions are
preferentially located on sun-exposed
sites. Nonsense mutations in two adja-
cent novel genes, named EVER1 and
EVER2, have recently been associated
with the disease in some consangui-
neous families and sporadic cases (Ra-
moz et al., 2002; Orth, 2006). Despite
these findings, we have recently de-
scribed an EV case with a lack of EVER
gene mutations and a remarkable
CD8þ T-cell lymphocytopenia (Azzi-
monti et al., 2005). Although EV has
recently been classified as a primary
deficiency in innate immunity to spe-
cific HPV genotypes (Notarangelo et al.,
2004), with the central role assigned to
keratinocytes, the molecular mechan-
isms underlying abnormal susceptibility
to a single type of weakly pathogenic
infectious agent are still unclear.
A 59-year-old woman was admitted
to our hospital with a diagnosis of EV.
Physical examination revealed a limited
number of multiple, flat, whitish and
reddish papular lesions on the hands
and forearms (Figure 1a and b) and a
few pityriasis versicolor-like lesions on
the trunk (Figure 1c). Surprisingly, the
patient had never developed either
cutaneous premalignant or malignant
lesions, even in sun-exposed areas;
thus, her forehead did not present any
erythematous lesions. As reported in
Figure 1d and e, biopsy specimens from
lesions of the forearm and hand showed
hyperkeratosis, acanthosis, and nume-
rous large cells with pale staining of the
cytoplasm and perinuclear vacuoliz-
ation in the spinous and granular layers,
resembling the typical histological fea-
tures of EV (de Oliveira et al., 2003).
This study was approved by the
Research Ethics Committee ‘‘Maggiore
Hospital’’ Novara and conducted ac-
cording to the Declaration of Helsinki
Principles. Written informed consent
was obtained from the patient.
HPV DNA analysis was performed
on samples collected with prewetted
cotton-tipped swabs from different sites
of the skin and on a formalin-fixed,
paraffin-embedded papular lesion from
a
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b c
Figure 1. Clinical and histological findings from the study patient. Flat whitish and reddish papular
lesions on the (a) hand and (b) forearm, (c) pityriasis versicolor-like lesions on the trunk. (d) A biopsy
specimen from a papular lesion on the right forearm shows hyperkeratosis and acanthosis. The inset
shows numerous large cells with pale staining of the cytoplasm and perinuclear vacuolization in the
spinous and granular layers. (e) A biopsy specimen from a flat wartlike papule on the back of the hand,
performed when she was 39 years old (1987), shows the same histopathological findings. Bar¼ 10 mm.
Abbreviations: ALPS, autoimmune lymphoproliferative syndrome; EV, epidermodysplasia verruciformis;
HPV, human papillomavirus; IL, interleukin; PRF1, perforin gene
732 Journal of Investigative Dermatology (2008), Volume 128
E Zavattaro et al.
Fas and Perforin Defects in an EV Patient
the forearm. The results obtained by
PCR analysis are shown in Table 1.
Genetic analysis of EVER1 (20 exons)
or EVER2 (16 exons) genes did not
detect any mutation that would result
in a loss of function. We only found a
nonsynonymous heterozygous single
nucleotide polymorphism in the EVER2
gene (rs7208422) in position 1289 of
the cDNA (numbering based on
GenBank accession no. NM_152468),
which caused the N306I amino-acid
substitution at the protein level.
Analysis of serum Ig levels by ELISA
showed that the patient displayed
mildly decreased levels of IgA and
normal amounts of IgM, IgG, and IgE
(Table 2). Immunophenotype analysis
of peripheral blood mononuclear cells
by two-color immunofluorescence and
flow cytometry (Table 2) showed a
low reduction of helper T cells
(CD3þCD4þ ) and a striking expansion
(9%) of an atypical T-cell population
expressing the TCRab, but double-
negative for both CD4 and CD8 (dou-
ble-negative T cells). The patient did
not develop a contact allergy to dinitro-
chlorobenzene sensitization, and the
purified protein derivative intradermal
test was also negative. Analysis of
cytokine secretion of peripheral blood
T cells stimulated with anti-CD3 mAb
showed a higher production of IL-10 in
comparison to healthy controls (Figure 2a).
Secretion of IL-4, IL-5, and tumor
necrosis factor-a was also significantly
increased. The proliferative response
and natural killer activity were in the
normal range (data not shown).
Expansion of double-negative T cells
is a hallmark of the autoimmune
lymphoproliferative syndrome (ALPS),
an inherited disease mainly due to
impaired apoptosis triggered by the
Fas (CD95) death receptor (Straus
et al., 1999; Dianzani et al., 2003;
Worth et al., 2006). Functional analysis
of the Fas gene, performed by using in
vitro-activated peripheral blood T cells
stimulated with an anti-Fas mAb, re-
vealed defective Fas function. By con-
trast, etoposide-induced cell loss, a
topoisomerase II inhibitor chemothera-
peutic agent that triggers a death path-
way independent of Fas, was in the
normal range (Figure 2b). Evaluation of
Fas expression in these cells by im-
munofluorescence and flow cytometry
detected normal levels (data not
shown). Despite the double-negative
T-cell expansion and defective Fas
function, the patient did not show any
clinical feature of ALPS.
Table 1. HPV DNA presence in skin samples from different sites1
Sample HPV type
Skin swabs
Hand (papular lesion) 5, 14
Neck (pityriasis versicolor-like lesion) 14
Forehead (no lesion) 5, 14
Cheek bone (no lesion) 5, 14, 38
Surgical specimen
Forearm (papular lesion) 14, 15, 24
1Skin samples collected with a saline-soaked cotton-tipped swab and from paraffin-embedded
surgical specimen.
Table 2. In vivo immunological analysis of the EV patient
Parameter Study patient Normal range
Serum
IgM 931 40–230
IgG 1,050 700–1,600
IgA 482 70–400
IgE 25 o150
PBMC immunophenotype
T cells
CD3+ 4653 (404) 425–503
CD3+CD4+ 2302 (20) 280–332
CD3+CD8+ 2265 (19) 163–213
TCRa/b+ CD4/CD8 DN 1055 (9) 14–28
CD3+/CD25+ 1615 (14) 114–149
CD3+/CD28+ 254 (22) 180–312
CD3+/CD45+RA 509 (44) 616–676
CD3+/CD45+RO 540 (46) 344–539
B cells
CD19+/CD20+ 217 (19) 110–243
NK cells
CD16+/CD56+ 29 (2) 15–47
Monocytes
CD14+ 78 (7) 54–104
Skin DTH response
DNCB — +++
PPD — +++
DTH, delayed-type hypersensitivity; DNCB, dinitrochlorobenzene; PBMC, peripheral blood mononuclear
cells; PPD, purified protein derivative.
Numbers in bold indicate statistically significant difference compared to the normal range.
1Values are expressed as international units (IU) per ml.
2Absolute number lower than the normal range.
3Values are expressed as median number of cells per ml (percentage of peripheral blood mononuclear
cells out of the total mononuclear cell population); similar results were obtained from blood sample
analyses performed over a 1-year period.
4Median percentage of lymphocytes.
5Absolute number higher than the normal range.
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ALPS is often caused by mutations of
the Fas gene (TNFRSF6), but mutations
of the FasL (TNFSF6), caspase-10
(CASP10), or caspase-8 (CASP8) genes
have also been occasionally reported
(Dianzani et al., 1997). Moreover, we
have recently shown that mutations of
the perforin gene (PRF1) and poly-
morphisms of the osteopontin gene
(SPP1) may cooperate with defective
Fas function in development of ALPS-
like diseases (Clementi et al., 2004,
2006). No mutation was detected
in TNFRSF6, CASP10, and CASP8,
whereas a missense variation in PRF1,
that is, a C/T substitution at position 272
of the cDNA (numerations are referred
to cDNA clone M28393, ATG¼ þ1),
which caused an A91V amino-acid
substitution, was found. She did not
carry the ALPS-associated allele of SPP1,
as she was homozygous for þ 1239A.
In summary, this study describes an
EV patient lacking mutations of the
EVER genes, but carrying several im-
munological alterations typically found
in patients with ALPS, such as peri-
pheral blood expansion of double-nega-
tive T cells, decreased Fas function, and
a strikingly increased secretion of IL-10.
In the study patient, no mutations were
detected in the Fas (ALPS type I) and
caspase-10 or caspase-8 gene (ALPS
type II). Therefore, her defect might
be similar to that of ALPS type III,
that is, ALPS lacking known mutations
and presumed to carry unknown
mutations of genes involved in the Fas
signaling pathway. Moreover, the
patient displayed the A91V variation
of the perforin gene that has been
associated with an incomplete variant
of ALPS.
A number of reports on viral disease
models, in which mice with deficien-
cies in one or more components of the
two cytolytic pathways were used,
demonstrated that perforin and Fas
concur in virus clearance (Kagi et al.,
1994; Balkow et al., 2001). In this
context, it can be postulated that both
Fas function and perforin defects may
contribute to the abnormal susceptibil-
ity of the study patient to cutaneous
HPV infection, possibly by decreasing
viral clearance in vivo. Consistent with
a role of defective cell-mediated cyto-
toxicity in some EV patients, we pre-
viously reported an EV patient
displaying a dramatic CD8þ T-cell
lymphocytopenia (Azzimonti et al.,
2005). Thus, a common pathogenetic
mechanism can be found in the re-
duced number or decreased cytotoxic
function of CD8þ T cells that may
impair the immune defenses against
HPV and lead to lifelong infection. It
remains to be explained why a cell-
mediated cytotoxicity defect would
selectively favor cutaneous HPV infec-
tion. One possibility is that the putative
mild cytotoxicity defect, carried by the
EV patient, may reveal itself only in the
skin environment, which is a peculiar
lymphoid tissue. A second, non-mu-
tually exclusive possibility is that addi-
tional genetic or environmental factors
may be present in such patients.
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Figure 2. Evaluation of cytokine secretion and T cell survival in the PBMC of the study patient.
(a) Cytokine secretion by peripheral blood mononuclear cells of the study patient versus healthy controls
(for each cytokine, results are expressed as fold induction above the media of the controls, referred to 1 as
represented by the dotted line). The peripheral blood mononuclear cells were stimulated with anti-CD3
mAb. Cytokines were measured on day-2-culture supernatants using a cytometric bead array kit.
Results shown are averages of two experiments. IL, interleukin; IFN, interferon; TNF, tumor necrosis
factor. (b) Fas- and etoposide-induced T-cell loss in the EV patient and three controls. T-cell lines derived
from each subject were treated with the indicated reagent, and cell survival was assessed after
18 hours. Results are expressed as % relative cell loss and are the mean7SD of two independent assays
for the patient (white bars) and three controls run in parallel (black bars). The horizontal lines indicate the
lower limit of the normal range calculated as the 5th percentile of data obtained from 200 normal
donors. In the control wells (i.e., in the absence of apoptotic stimuli), spontaneous cell loss was always
o10% of the seeded cells and was similar to that in cultures from the patients and normal donors.
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TO THE EDITOR
Data from population studies show that
obese people tend to have higher rates
of infection and cancer (Choban et al.,
1995; Engel et al., 2003). This led us
to hypothesize that those who are
obese may have impaired immunity
mechanisms.
Recently, we found that diet-in-
duced obese (DIO) mice had impaired
contact hypersensitivity (CHS) res-
ponses to 2,4,6-trinitrochlorobenzene
(TNCB), but that their Langerhans cell
function and delayed-type hypersensi-
tivity response to ovalbumin were not
affected (Katagiri et al., 2007). Thus, the
impaired CHS response might be re-
lated to obesity; non-obese BALB/c
mice that received the same high-fat
diet (HFD) did not experience changes
in their CHS responses to TNCB (Kata-
giri et al., 2007). The HFD has a high
fatty-acid content, which might affect
the immune response (Yaqoob, 2003).
We designed this study to examine the
impairment mechanisms that affect
CHS response in DIO mice and to
determine whether it is the obesity or
the HFD that is responsible for the
impairment.
Female C57BL/6 mice were pur-
chased from Kyudo Co. (Fukuoka,
Japan) and were 6-weeks old at the
time of experimentation. The mice
were treated in accordance with the
Oita University Guidelines for the Care
and Use of Laboratory Animals. To
induce obesity, we fed one group of
mice a high-fat, high-calorie diet sup-
plemented with sucrose and safflower
oil (oleic acid-rich oil) (S-HFD). The
other group of mice was fed a normal
diet (ND). During some experiments, a
panel of mice was fed a commercially
available HFD (O-HFD) (Oriental Yeast
Co., Tokyo, Japan), in which the fat
consisted of soybean and lard (see
details in the figure legends). CHS
experiments were performed at least 6
weeks after the mice began their
assigned diets. The mice were sensi-
tized with TNCB, oxazolone, or FITC
Abbreviations: CHS, contact hypersensitivity; DIO, diet-induced obese; HFD, high-fat diet; ND, normal
diet; O-HFD, another type of commercially available high-fat diet; S-HFD, high-fat and high-calorie diet
supplemented with sucrose and safflower oil; TNCB, 2,4,6-trinitrochlorobenzene
www.jidonline.org 735
K Katagiri et al.
Contact Hypersensitivity in Diet-Induced Obesity
